FORD WILLIAM E — SEC insider filings
SEC reporting owner CIK 1193345. 43 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 43 filings on record, filed 2020-09-14 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 3,000 shares, $2,063,880 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: purchase of 2,000 shares @ $681.44 ($1,362,880) in BlackRock Inc., filed 2022-04-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BlackRock Inc. (BLK) | Director | 21 | 2 legs · 3,000 sh · $2,063,880 | — | 20 |
| BlackRock, Inc. (BLK) | Director | 11 | — | — | 11 |
| IHS Markit Ltd. (INFO) | Director | 8 | — | — | 9 |
| Royalty Pharma plc (RPRX) | Director | 3 | — | — | 5 |
Insider filings — FORD WILLIAM E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 34 @ $0 | EDGAR |
| 2026-07-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 37 @ $0 | EDGAR |
| 2026-04-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 38 @ $0 | EDGAR |
| 2026-01-21 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 214 @ $0 | EDGAR |
| 2026-01-05 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 34 @ $0 | EDGAR |
| 2025-10-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 31 @ $0 | EDGAR |
| 2025-07-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 35 @ $0 | EDGAR |
| 2025-04-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 38 @ $0 | EDGAR |
| 2025-01-17 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 250 @ $0 | EDGAR |
| 2025-01-03 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 35 @ $0 | EDGAR |
| 2024-10-02 | 4 | BlackRock, Inc. (BLK) | Grant/award (A): 34 @ $0 | EDGAR |
| 2024-07-02 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 42 @ $0 | EDGAR |
| 2024-04-01 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 39 @ $0 | EDGAR |
| 2024-01-18 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 300 @ $0 | EDGAR |
| 2024-01-03 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 40 @ $0 | EDGAR |
| 2023-10-03 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 50 @ $0 | EDGAR |
| 2023-07-05 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 47 @ $0 | EDGAR |
| 2023-04-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 49 @ $0 | EDGAR |
| 2023-01-19 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 323 @ $743.61 | EDGAR |
| 2023-01-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 45 @ $0 | EDGAR |
| 2022-10-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 59 @ $0 | EDGAR |
| 2022-07-01 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 54 @ $0 | EDGAR |
| 2022-04-18 | 4 | BlackRock Inc. (BLK) | Purchase (P): 1,000 @ $701 · Purchase (P): 2,000 @ $681.44 | EDGAR |
| 2022-04-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 43 @ $0 | EDGAR |
| 2022-03-02 | 4 | IHS Markit Ltd. (INFO) | Disposition to issuer (D): 50,621 @ $0 · Disposition to issuer (D): 1,680 @ $0 | EDGAR |
| 2022-01-20 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 288 @ $832.07 | EDGAR |
| 2022-01-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 35 @ $0 | EDGAR |
| 2021-12-17 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 228 @ $0 | EDGAR |
| 2021-10-04 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 39 @ $0 | EDGAR |
| 2021-09-16 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 246 @ $0 | EDGAR |
| 2021-07-02 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 44 @ $0 | EDGAR |
| 2021-06-30 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 871 @ $43.04 | EDGAR |
| 2021-06-29 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 5,726 @ $0 | EDGAR |
| 2021-06-17 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 280 @ $0 | EDGAR |
| 2021-05-07 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 1,680 @ $0 | EDGAR |
| 2021-04-05 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 47 @ $0 | EDGAR |
| 2021-03-17 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 324 @ $0 | EDGAR |
| 2021-02-26 | 4 | Royalty Pharma plc (RPRX) | Conversion (C): 581,870 @ $0 · Other (J): 42,101 @ $0 · Conversion (C): 58,187 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 325 @ $0 | EDGAR |
| 2021-01-05 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 48 @ $0 | EDGAR |
| 2020-12-17 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 309 @ $0 | EDGAR |
| 2020-10-02 | 4 | BlackRock Inc. (BLK) | Grant/award (A): 62 @ $0 | EDGAR |
| 2020-09-14 | 4 | IHS Markit Ltd. (INFO) | Grant/award (A): 281 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1193345 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs